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Esophageal cancer is a deadly cancer with 5-year survival <20%. Although multiple risk fac-
tors for esophageal adenocarcinoma (EAC) including obesity, GERD and smoking have
been identified, these risk factors do not fully explain the rising incidence of EAC. In this
study, we evaluated the association between prior history of tonsillectomy and EAC. Our
goal was to determine whether tonsillectomies were more frequent in patients with EAC
(cases) than in our thoracic surgery controls.
Methods
Cases included 452 esophagectomy cases, including 396 with EAC and 56 who underwent
esophagectomy for Barrett’s esophagus (BE) with high grade dysplasia (HGD). 1,102 tho-
racic surgery patients with surgical indications other than dysplastic BE or esophageal can-
cer represented the controls for our analysis. The association of tonsillectomy and HGD/
EAC were primarily evaluated by using univariate tests and then verified by logistic regres-
sion analysis. Baseline demographics, medical history, and thoracic surgery controls were
compared by using χ2 tests or 95% CIs. Significant risk factors were considered as covari-
ates in the multivariate models while evaluating the association between tonsillectomy and
HGD/EAC. P-values or odds ratios were estimated with 95% confidence limits to identify sig-
nificances which was more appropriate.
Results
Tonsillectomy was more common in cases than controls and was found to have a significant
association with esophageal cancer (19.9% vs. 12.7%; p-value = 0.0003). This significant
association persisted after controlling for other known risk factors/covariates.
PLOS ONE
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Conclusion
A prior history of tonsillectomy was significantly associated with HGD/EAC and may repre-
sent an independent risk factor for the development of EAC. However, the underlying biol-
ogy driving this association remains unclear.
Introduction
Esophageal cancer remains a deadly cancer with a 5-year survival<20% [1]. While traditionally
esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) have been
grouped together, recent genomic data demonstrate that these are two distinct cancer types [2].
Gastroesophageal reflux disease (GERD) and obesity and tobacco use are major risk factors for
EAC [1, 3]. Screening and surveillance are performed for Barrett’s Esophagus (BE), the only
known precursor lesion for EAC. However, given that EAC only occurs in a small percentage of
patients with BE, identification of individuals at higher risk for disease remains a challenge [4].
An incomplete understanding of factors that increase risk for EAC continues to hamper efforts
to develop meaningful prevention and treatment measures that reduce mortality.
Esophageal carcinoma affects over 450 000 people worldwide and the EAC subtype remains
one of the few cancers with steadily increasing incidence and death rates [5, 6]. The incidence
of EAC in the United States increased six-fold from 1975 to 2001, representing a relatively
greater increase than other cancers including breast and prostate [7]. Pohl et al. concluded that
this rise represents a true increase in burden of disease, perhaps due to a novel risk factor,
rather than a consequence of changes in classification or diagnostic criteria [7]. Although
increasing obesity rates and smoking have been identified as age-dependent risk modifiers,
novel exposures or risk factors to explain this dramatic increase in incidence are yet to be iden-
tified [3].
A tonsillectomy, which involves removal of the tonsil or tonsillar capsule, is a common sur-
gical procedure with over 500 000 procedures performed annually on children younger than
15 in the United States [8]. This procedure, reported as the most frequently performed surgical
procedure in the early 20th century, became less common in the late 1970s with increased use
of antibiotics [8]. This declining trend in tonsillectomy has reversed as indications for tonsil-
lectomy have shifted from infectious indications to sleep disordered breathing, which now rep-
resents the most common indication for tonsillectomy [8]. The tonsillectomy procedure,
formerly thought to be benign, has been associated with increased risk for adult diseases [9–
11], perhaps due to subsequent dysregulation of immune mechanisms. Tonsils are essential
immune organs that protect the body from incoming bacteria and other pathogens. Tonsillec-
tomies may cause changes to cellular and humoral immune function including changes to
immunoglobulin production; while these immunologic changes have not been clinically signif-
icant in the pediatric population [12–14], more recent studies have shown that tonsillectomy
may increase long-term risk for deep neck infection and malignancy [9, 10].
In our study, we used a case-control study design for an initial exploration of the association
between the increase in tonsillectomies after the 1920’s and HGD/EAC using thoracic surgical
cases and controls.
Methods
The study was approved by the Duke Institutional Review Board (IRB Protocol Pro00039682)
on 07/31/2012 with a waiver of informed consent. Consent was waived because the study
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involved secondary analysis of existing data and involved no more than minimal risk to the
subjects. The study was performed in accordance with the Declaration of Helsinki, Good Clin-
ical Practice, and applicable regulatory requirements.
Study population
We recruited cases from a database of 603 patients who underwent esophagectomy at our
institution between the years 2000 and 2010. Of the 603 patients, 452 represent the cases in our
analysis, including patients who had EAC of the esophagus or gastroesophageal junction (GEJ)
(n = 396) as well as patients who underwent esophagectomy for BE with high grade dysplasia
(HGD) (n = 56). The esophagectomy cohort also included 81 patients with ESCC, but these
were excluded from the primary analysis.
A control cohort was created from patients who had undergone surgical thoracic proce-
dures. We identified 65 control patients from the esophagectomy cohort with benign esoph-
ageal disease (n = 46), other tumor such as a metastatic lesion (n = 11) or other cause (n = 8).
We also recruited an additional 1037 thoracic controls from a large registry of 4750 thoracic
surgery patients who underwent thoracic procedures other than esophagectomy. In selecting
these additional thoracic surgery controls, patients with esophagectomy or HGD/EAC or a
prior diagnosis of esophageal cancer were excluded. The rationale for this approach was based
upon similar exposure to a thorough surgical and anesthesia history, including proper docu-
mentation of a surgical procedure like tonsillectomy. The initial sorting process excluded
duplicate patients and generated 2775 unique potential controls. Patient inclusion for the con-
trol group were considered in conjunction with the statisticians on our study team and was
based upon distribution of age and gender i.e. including patients within the interquartile range
of ages stratified by gender. A chart-review was performed that excluded any other patients
from the additional thoracic surgery controls with known history of esophageal cancer or eso-
phagectomy; this resulted in exclusion of additional patients and affected the age and sex dis-
tribution of the control group. Those demographic factors were accounted for in the adjusted
analysis. Indications for thoracic procedures were benign lung disease, mediastinal disease,
pleural disease or infection, and “other”. The total control group for analysis included 1102
thoracic surgical patients.
Chart review
We conducted an Electronic Health Record (EHR) chart review using a pre-determined chart-
abstraction form for cases and controls. Chart review was conducted by two independent
reviewers as a part of an internal validation process for accuracy. Specifically, we noted surgical
history including tonsillectomy status as listed in peri-operative and anesthesia reports. Given
the chart-review nature of this study, details about timing and indication for tonsillectomy
were often not available. However, when date of tonsillectomy was available, this was noted
and qualitatively described. Data abstraction for cases included esophageal cancer specific sub-
type. BE was defined as columnar epithelium with goblet cells. Prior diagnosis of dysplasia
(non-dysplastic, low grade dysplasia, or high-grade dysplasia) was noted. Many patients were
referred from outside hospitals and length of Barrett’s segment was missing for many patients
and thus could not be included in the analysis. For both cases and controls, demographic fac-
tors as well as comorbidities including previous cancer history, and potentially relevant expo-
sures including GERD, prior BE diagnosis, alcohol use, tobacco use, proton pump inhibitor
(PPI) and aspirin use were all recorded [1]. Given previous work showing that quitting smok-
ing is not associated with a strong reduction in risk for EAC [15], a combined variable of any
tobacco use was used in the primary analysis. A similar method was adopted for alcohol use.
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Due to the association of obesity with BE and EAC, we calculated BMI from height and weight
at the time of thoracic surgery from weight and height available in the electronic medical
record. While weight was recorded for most patients, height was missing for about half of the
patients. Research Electronic Data Capture (REDCap) software, a secure, web-based applica-
tion designed to support data capture for research studies, was used to create the research data-
base [16]. A de-identified version of this database was then used for data analysis.
Statistical analysis
This retrospective cohort study was designed to detect the association of tonsillectomy with
HGD/EAC with over 80% power to and 5% significance level. Our primary outcome measure
was presented as the frequencies and proportions by case and control. The association was
measured by odds ratios (ORs) with 95% confidence intervals (CIs) and generated by using
univariate tests, and then verified by multivariate logistic models with the considerations of
associated covariates. Differences in demographics, clinical risk factors and comorbidities
between cases and controls were preliminarily identified using a Pearson χ2 test or t-test. Rates
of GERD and history of tonsillectomy were reported as frequencies (percentage) or mean
(standard deviation).
Due to the high frequency of missing BMI data, we applied a model-based imputation
approach that used simulated values to address the influence of missing values on results. By
fitting the multivariate logistic/regression models with non-missing data, missing values were
imputed from the posterior predictive distribution of the parameters. For BMI classification,
obesity was defined as a BMI of 30 or more [17, 18]. Missing values in BMI were simulated by
considering age, gender, height, weight, and race indices as the predictors. For missing values
of tobacco use, age, gender, and race indices, prior tobacco, and ETOH status were included.
Similarly, missing values for alcohol use were simulated by age, gender, and race indices, his-
torical ETOH, and the tobacco use status.
Univariate and multivariate logistic regression analysis was used to generate unadjusted or
adjusted estimation of the ORs (both point and interval estimation), which detected the associ-
ation between HGD/EAC and baselines or between tonsillectomy with selected HGD/EAC
risk factors (age, gender, BMI, race, GERD, history of BE, ever using tobacco and ever using
alcohol). Stepwise model selection and clinical were both taken into our considerations to
illustrate these relationships.
Finally, we further evaluated the relationship between HGD/EAC and tonsillectomy with
incorporating all known HGD/EAC risk factors in a multivariate logistic model. Different
models with or without missing imputations had been considered allowing assessment of the
potential impact of the missing values on results.
The models were developed using existing data and also after imputing missing data to
determine odds ratios to describe the association between tonsillectomy and other variables on
risk of HGD/EAC. Statistical analysis was performed using SAS software, version 9.4 (Cary,
NC, USA). SAS and all other SAS Institute Inc. product or service names are registered trade-
marks or trademarks of SAS Institute Inc., Cary, NC, USA. Version 9.4 SAS Software, Copy-
right 2013.
Results
Demographic distribution and medical history of cases and controls
Given known racial and gender distribution of EAC, as expected, patients with HGD/EAC
were more likely to be white and male. While we had initially filtered control subjects by age,
some of the selected controls did not meet inclusion criteria after more detailed chart review,
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changing the demographics of the final control group. However, overall, no significant differ-
ence in age was detected between the two populations.
Due to the known natural history of EAC, in the unadjusted analysis, a history of BE,
GERD and PPI use were all more common in cases versus controls, as reported in Table 1.
Due to study design, rates of BE in the control group were very low. Rates of exposures to risk
factors associated with HGD/EAC, such as tobacco and alcohol were high in both groups, but
significantly higher among cases (Table 1). Prior rates of non-esophageal cancer were found to
be higher in thoracic surgery control group than in the esophageal cancer case group. Simi-
larly, frequencies of comorbid conditions such as lung disease, liver disease and kidney disease
were higher in controls than in cases (Table 1). However, metabolic diseases including diabetes
mellitus, history of myocardial infarction and cardiovascular disease were similar between
groups; use of a statin medication was also similar between groups. BMI was also similar
between both groups. 25% of cases versus 1% of control patients had a reported history of BE
(Table 1).
Distribution of dysplasia and esophageal cancer subtypes in the
esophagectomy cohort
Distribution of the types of esophageal cancers within the esophagectomy database was consis-
tent with the known higher rates of EAC compared with ESCC in the US; most of the esoph-
ageal cancers were of the adenocarcinoma subtype. The 81 ESCC cases in the esophagectomy
database were not included in the primary case-control analysis. In the 452 cases of EAC/
HGD from the esophagectomy cohort, only 113 (25%) had a prior known history of BE. As
suggested by the literature [19], diagnosis of BE generally did not precede diagnosis of cancer.
It is also important to note that based upon pathologic description, BE was not always detected
on pathologic assessment of the cases at esophagectomy; of all the 452 HGD/EAC cases, 45.8%
did not include a final pathologic description of BE. Of the 396 EAC cases, when the BE adja-
cent to the EAC was evaluated for the presence of dysplasia after esophagectomy, 52.3% of
pathology reports suggested no BE was present, 20.7% had non-dysplastic BE, 4.0% had LGD,
15.6% had HGD and 7.1% had intramucosal adenocarcinoma. Within the cohort of 452 HGD/
EAC cases, 264 tumors were at the GEJ. In the selected group of GEJ cancers, 91.3% did not
have a known history of BE and 70.5% did not include a pathologic description of BE on the
pathology report at the time of esophagectomy.
Prior history of tonsillectomy was associated with increased risk for HGD/
EAC
As illustrated in Fig 1, of the HGD/EAC cases in our analysis, a total of 90 (19.9%) cases had a
prior history of tonsillectomy compared to a total of 140 control group patients (12.7%) with a
prior history of tonsillectomy (p-value 0.0003) (Fig 1). In a univariate analysis, patients with a
prior history of tonsillectomy were more likely to have HGD / EAC compared to those with no
prior history of tonsillectomy OR 1.7 (95% CI 1.3–2.3). This association persisted even after
adjustments for covariates OR 1.8 (95% CI 1.2–2.7).
Due to the chart-review nature of the study, data in the medical record were incomplete
regarding timing of tonsillectomy; surgical history often listed the procedure without addi-
tional information such as timing. A review of the 603 esophagectomy patients revealed that
for seven patients, a qualitative description of timing of tonsillectomy was provided and in all
these instances, tonsillectomy had been performed in childhood (n = 5), remotely or in the
patient’s 20s (at least five decades before esophagectomy). For the 25 instances where a year of
tonsillectomy was provided, 22 of the 25 were between the 1930s and 1970s (at least 30 years
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prior to the esophagectomy) and only 3 of the 25 were in the 2000s, closer to the time of
esophagectomy.
Next, we evaluated the association between known HGD/EAC risk factors and tonsillec-
tomy. White race, history of GERD and coronary artery disease (CAD) were all associated
Table 1. Baseline characteristics and medical history for HGD/EAC cases and thoracic surgery controls.
Characteristic Case N = 452 (29%) Control N = 1,102 (71%) Overall N = 1,554 P-values to detect a difference
Age Mean (SD) 63 (10) 62 (6) 62 (7) 0.041
Male N (%)� 395 (87) 620 (56) 1,015 (65) <.001
BMI Obesity N (%) 47% missing 47 (29) 206 (31) 253 (31) 0.564
Race- White N (%)� 424 (94) 885 (80) 1,309 (84) <.001
GERD N (%)� 268 (59) 454 (41) 722 (46) <.001
Proton Pump Inhibitor N (%)� 289 (64) 402 (37) 691 (44) <.001
H2 blocker use N (%)� 16 (4) 78 (7) 7 (6) 0.008
ASA use N (%)� 81 (18) 365 (33) 446 (29) <.001
NSAID use N (%) 18 (4) 63 (6) 81 (5) 0.163
Statin use N (%) 106 (23) 244 (22) 350 (23) 0.575
Barrett’s esophagus N (%)� 113 (25) 15 (1) 128 (8) <.001
Peptic ulcer disease N (%)� 40 (9) 49 (4) 89 (6) 0.001
Previous History of cancer N (%)� 81 (18) 432 (39) 513 (33) <.001
Diabetes mellitus N (%) 93 (21) 256 (23) 349 (22) 0.255
Myocardial infarction N (%) 49 (11) 102 (9) 151 (10) 0.338
Coronary artery disease N (%) 90 (20) 230 (21) 320 (21) 0.671
Lung disease N (%)� 110 (24) 656 (60) 766 (49) <.001
Liver disease N (%)� 11 (2) 55 (5) 66 (4) 0.023
Kidney disease N (%)� 41 (9) 170 (15) 211 (14) 0.001
Ever Tobacco N (%)� 6% missing 338 (81) 711 (68) 1049 (72) <.001
Ever Alcohol N (%)� 18% missing 232 (66) 356 (39) 588 (46) <.001
� Factors significantly different between case versus control were identified based on Chi-square test or the estimated 95% confidence intervals (95% CIs) of means.
Please note that the p-value for Age was lower than 0.05 but the 95% CI were overlapping (61.7–63.6) for case and (61.2–61.9) for controls, which did not imply
significance.
https://doi.org/10.1371/journal.pone.0235906.t001
Fig 1. Illustration of our study showing the distribution of tonsillectomy in our cases and controls in relation to
known risk factors for HGD/EAD.
https://doi.org/10.1371/journal.pone.0235906.g001
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with a history of tonsillectomy (Table 2). In Table 3, we adjusted odds ratios using multivariate
logistic regression with or without missing imputation. Despite the different models, the ORs
were similar with consistent association of white race, reflux history and CAD with tonsillec-
tomy (Table 3).
Next, a multivariate logistic regression analysis was performed in order to evaluate the asso-
ciation between tonsillectomy and EAC/HGD. These results are presented in Table 4. Male
sex, white race and PPI use were strongly associated with HGD/EAC as was ETOH use. As
expected, having ever used tobacco was a significant risk factor for EAC/HGD with OR 1.5
(1.06–2.24), after imputation. Interestingly, ASA use was protective for HGD/EAC in this
case-control analysis with OR 0.3 (95% CI 0.17–0.39). Importantly, variables were created to
determine if there was any effect of the missing data for BMI and tobacco use; having missing
BMI data (versus being underweight) was associated with EAC. Consequently, multivariate
analysis was performed with and without missing BMI imputation and overall, the association
between prior tonsillectomy and EAC/HGD persisted (Table 4).
Discussion
Our single center case-control study presents a new association between prior tonsillectomy
and HGD/EAC, when compared with other thoracic surgery control patients. This represents
an association that, to our knowledge, has never been reported before. Particular strengths of
our study include our large cohort (452 cases and 1102 controls), surgical patient populations
Table 2. Association between various known risk factors for EAC and prior tonsillectomy are presented here.
Characteristics Levels Tonsillectomy N = 230 (15%) p-values Odds Ratios (95% CI)
Age Difference from non-Tonsillectomy Mean (SD) 0.4(7) 0.439 1.0 (0.99, 1.03)
Gender Male 140 (17%) 0.125 0.8 (0.60, 1.07)
Female 90 (14%) - ref
BMI BMI Obesity 40 (16%) 0.610 1.1 (0.75, 1.71)
BMI Normal to Overweight 82 (14%) - ref
N/A 108 (15%) 0.954 1.1 (0.77, 1.51)
Race� White 210 (16%) 0.002 2.2 (1.33, 3.48)
Non-white 20 (8%) - ref
GERD� Yes 128 (18%) 0.003 1.5 1.16, 2.04)
No 102 (12%) - ref
Barrett’s esophagus Yes 22 (17%) 0.428 1.2 (0.75, 1.97)
No 208 (15%) - ref
Coronary artery disease� Yes 31 (10%) 0.004 0.6 (0.37, 0.83)
No 199 (16%) ref
Ever tobacco Yes 153 (15%) 0.705 1.0 (0.70, 1.32)
No 62 (15%) - ref
N/A 15 (16%) 0.805 1.1 (0.57, 1.95)
Ever alcohol Yes 100 (17%) 0.081 1.3 (0.99, 1.83)
No 91 (13%) - ref
N/A 39 (14%) 0.655 1.1 (0.71, 1.59)
� Odds Ratios (ORs) describe the association of each risk factor with tonsillectomy.
� Factors significantly associated with Tonsillectomy were concluded based on the 95% Confidence Interval of ORs. White race, GERD, and CAD were associated with a
history of tonsillectomy.
� We didn’t identify significant differences from the missing groups for BMI, tobacco, and alcohol.
https://doi.org/10.1371/journal.pone.0235906.t002
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with similar data collection practices, and rigorous data analysis that accounted for missing
data points and adjusted for several potential covariates. Based upon those strengths, the
intriguing association between tonsillectomy and prior history of tonsillectomy merits further
research. In particular, validation in population-based cohort would be an important next
step. An additional secondary finding from this analysis was a negative association between
aspirin use and HGD/EAC. Other recent studies have also noted the potentially protective
effect of aspirin in combination with high-dose PPI in reducing all-cause mortality [20].
Tonsillectomy has been reported to have age-dependent associations with other malignan-
cies, including various head and neck cancers [9, 21]. Fakhry et al in their study using data
from the Denmark Cancer Registry, demonstrated that tonsillectomy increases the incidence
of both tonsil and base of tongue cancers in patients over 60 years but may have a protective
effect against tonsil cancers in patients under 60 years of age [9]. Zevallos et al, also showed
that tonsillectomy performed before the age of 13 significantly increased the risk for cancer at
the base of the tongue [21]. The rise of tonsillectomies can be traced back to the early 20th cen-
tury when it was common practice to perform tonsillectomy as treatment for throat infections.
The procedure was considered relatively benign and effective. Indeed, between 1915 and 1960,
tonsillectomy was the most popular surgical procedure in the US [8]. However, with the
increased use of antibiotics in clinical practice in the mid 20th century, a greater than 50%
decline in tonsillectomies was reported between 1977 and 1989 [22]. Our findings suggest that
that tonsillectomies may predispose patients to adult malignancies such as EAC many years
later, correlating with the rise in EAC noted in the 1970s. Incidence of tonsillectomies has
again risen over the past 35 years, although the most common indication for the procedure has
shifted from recurrent infection to sleep disordered breathing [8]. The recent resurgence from
its application as treatment for sleep disordered breathing may also be related to obesity, a fac-
tor we controlled for in this analysis.
A possible biologic explanation for the association between tonsillectomy and EAC relates
to potential immune dysregulation associated with tonsillectomy that disrupts the esophageal
and/or intestinal microbiome, increasing chronic exposure to harmful bacteria and
Table 3. Adjusted analyses of relationship between known EAC risk factors with prior tonsillectomy.
Characteristics Levels ORs Unadjusted ORs Adjusted1 ORs Adjusted2 ORs Adjusted3
Age Continuous 1.0 1.0 1.0 1.0
Gender Male (ref: Female) 0.8 0.8 0.7� 0.7�
BMI Obesity (ref: Under) 1.1 1.1 1.2 1.2
N/A (ref: Under) 1.1 - 1.1 -
Race White (ref: Non-white) 2.2� 2.2� 2.1� 2.1�
GERD Yes (ref: No) 1.5� 1.5� 1.5� 1.5�
Barrett’s esophagus Yes (ref: No) 1.2 1.2 1.0 1.0
Coronary artery disease Yes (ref: No) 0.6� 0.6� 0.6� 0.6�
Ever tobacco Yes (ref: No) 1.0 1.0 1.0 1.0
N/A (ref: No) 1.1 - 1.2 -
Ever alcohol Yes (ref: No) 1.3 1.4� 1.4 1.4�
N/A (ref: No) 1.1 - 1.0 -
� Unadjusted ORs, as well as ORs adjusted to account for missing BMI, tobacco use and alcohol use data are presented. OR estimates were calculated using patients
without Tonsillectomy as the reference group. Columns represented include: 1) Unadjusted ORs, 2) Adjusted ORs calculated univariately after imputation, 3) Adjusted
ORs calculated by multivariate logistic regression with all variables included, and 4) Adjusted ORs calculated by multivariate logistic regression with all variables
included after imputation for missing data. Factors significantly associated with Tonsillectomy were concluded based on the 95% Confidence Interval of ORs.
https://doi.org/10.1371/journal.pone.0235906.t003
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uncontrolled stimulation of inflammatory pathways. Tonsils are known to be sentinel immune
organs that protect the digestive tract from foreign pathogens and bacteria [23]. Tonsil dys-
function or removal may therefore impair the natural protective effect against incoming bacte-
ria and/or disrupt the existing bacterial ecosystem. Studies have shown reduced levels of
secretory immunloglobulins such as IgA after tonsillectomy. Mucosal IgA is needed as protec-
tion from mucosal pathogens; when IgA levels fall, this could contribute to increased proin-
flammatory signalling and risk for disease [24]. Other studies have shown that the esophageal
microbiome is consistently altered in patients with GERD, BE and EAC, with increased preva-
lence of gram negative bacteria such as Fusobacterium, Bacteroides, Veillonella, and Escerichia
coli and decreased prevalence of gram positive bacteria like Streptococcus spp. [25–32].
Although still unclear, it has been suggested that this shift in the microbiome from gram posi-
tive to more gram negative composition may trigger toll like receptors (TLR) such as TLR3
and TLR4 and increase expresson of downstream cytokines such as IL-8 and NFkB that pro-
mote inflammation associated carcinogenesis [27, 33]. Other factors such as the presence of H.
pylori and increased microbial diversity, have shown a protective trend against EAC [25, 34–
36]. Whether tonsilar dysfunction or removal increases esophageal neoplastic risk by impair-
ing mucosal defense against harmful pathogens, directly modifying the esophageal/intestinal
Table 4. Multivariate logistic regression to evaluate associations between tonsillectomy, esophageal adenocarcinoma, and other covariates. Two ORs are presented
for each variable: 1) Before imputation of missing values (BMI, tobacco, alcohol); 2 After imputation of missing values.
Effect OR1 95% Wald CI OR2 95% Wald CI
Tonsillectomy 1.8� (1.16,2.74) 1.8� (1.19, 2.74)
Age 1.0� (1.01, 1.05) 1.0� (1.01, 1.05)
Gender (Male /Female) 8.6� (5.64, 13.16) 8.5� (5.66, 12.89)
BMI (Obesity vs Under) 0.9 (0.56, 1.56) 1.2 (0.86, 1.65)
(NA vs Under) 2.7� (1.91, 3.87) - -
White/Non-White 3.1� (1.81, 5.29) 3.0� (1.75, 5.00)
GERD 1.2 (0.80, 1.66) 1.1 (0.76, 1.55)
PPI use 2.6� (1.84, 3.81) 2.6� (1.79, 3.64)
H2 blocker use 0.4� (0.19, 0.93) 0.5� (0.22, 0.98)
ASA use 0.3� (0.18, 0.42) 0.3� (0.17, 0.39)
NSAID use 0.7 (0.31, 1.39) 0.6 (0.31, 1.26)
Statin use 1.4 (0.94, 2.18) 1.2 (0.81, 1.83)
History of BE 21.2� (10.67, 42.06) 23.0� (11.63, 45.65)
Peptic ulcer disease 1.2 (0.66, 2.28) 1.1 (0.62, 2.11)
Previous History of Cancer 0.3� (0.18, 0.39) 0.3� (0.18, 0.38)
Diabetes mellitus 1.0 (0.64, 1.46) 0.9 (0.61, 1.39)
Myocardial infarction 1.0 (0.50, 1.87) 1.1 (0.59, 2.17)
Coronary artery disease 1.0 (0.56, 1.64) 0.9 (0.56, 1.59)
Lung disease 0.1� (0.10, 0.19) 0.1� (0.10, 0.19)
Liver disease 0.5 (0.19, 1.11) 0.5 (0.19, 1.11)
Kidney disease 0.4� (0.25, 0.68) 0.5� (0.29, 0.77)
Ever tobacco (Yes/No) 1.4 (0.92, 2.10) 1.5� (1.06, 2.24)
Ever tobacco (N/A/No) 0.9 (0.40, 1.86) - -
Ever alcohol (Yes/No) 2.7� (1.83, 3.85) 2.0� (1.49, 2.81)
Ever alcohol (N/A/No) 2.1� (1.31, 3.53) - -
� OR estimates were calculated using thoracic surgery controls as reference group. Factors significantly associated with HGD/EAC were concluded based on the 95%
Confidence Interval of ORs.
https://doi.org/10.1371/journal.pone.0235906.t004
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microbiome, or by stimulating chronic inflammation remains unknown and may be a promis-
ing area for future research. Fig 2 proposes potential mechanisms that could connect the risk
HGD/EAC with tonsillectomy and while these are speculative, they present interesting avenues
for more mechanistic research.
Other possible mechanisms, such as the presence of underlying genetic drivers, might be
associated with both tonsillectomy and other conditions associated with EAC. Genome wide
association studies have emphasized that GERD is a polygenic disease, and have shown an
association between multiple GERD single nucleotide polymorphisms (SNPs) and the devel-
opment of BE and EAC [37]. When we controlled for clinical GERD, prior history of tonsillec-
tomy remained an independent risk factor for EAC. Given the complexity of both GERD and
tonsillitis, we explored other underlying genetic factors that could be associated with GERD
and tonsillectomy. Studies have implicated risk loci associated with childhood tonsillectomy in
SH2B4 and HLA-B genes [38]; these risk loci are also associated with increased risk for GERD
[37]. While further exploration of associations between risk loci for tonsillectomy, GERD, BE
and EAC are needed, another study suggested that functional polymorphisms in the immune-
related gene for human beta defensin (DEFB1) were associated with increased susceptibility to
adeno-tonsillar hypertrophy [39]. As illustrated with proposed mechanisms in Fig 2, it is possi-
ble that underlying genetic factors related to immune function could be associated with
GERD, tonsillectomy and cancer development. Further population-based studies with geno-
mic components as well as multi-center prospective trials may be required to better under-
stand genetic links between tonsillectomy, immune function, and EAC.
Our study has several strengths, but it also has some limitations, many of which are inher-
ent to the case-control, single-center, study design. First, although our rigorous imputation
analysis accounts for missing BMI data, it is unlikely to completely eliminate the risk of con-
founding bias from obesity. Given the available data, it was not possible to control for prior
remote antibiotic exposure, another potential confounder shown in a recent study from the
UK to have a dose-dependent association with EAC [40]. Next, self-reported data presents a
risk of recall bias, but previous studies have reported a sensitivity as high as 92.7% and specific-
ity of 77.5% of tonsillectomy recall, and so we do not believe recall bias significantly impacted
our results [21, 41]. Finally, our study was underpowered to determine associations between
Fig 2. Illustration depicting possible association between tonsillectomy, inflammatory dysregulation, known EAC
risk factors and development of EAC. Inflammatory dysregulation is proposed as an area for future investigation
rather than as an established mechanism of disease.
https://doi.org/10.1371/journal.pone.0235906.g002
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ESCC and tonsillectomy, as the relatively small number of ESCC cases limited our ability to
draw conclusions on statistical significance. However, rates of tonsillectomy in ESCC cases
were similar to controls. Despite these limitations, as efforts to prevent and treat EAC con-
tinue, and the incidence of tonsillectomy continues to rise, we believe our study offers an
important novel association between tonsillectomy and EAC. However, we would caution cli-
nicians to avoid making any conclusions about causality based upon these data. Indeed, tonsil-
lectomy remains a relatively common procedure and esophageal cancer is still quite rare. The
odds ratio associated with tonsillectomy is modest at best and should not imply causality. That
said, the work presented here provides a basis for future studies that might test the validity of
these findings on a population level and explore potential biological mechanisms underlying
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